One of the smallcap stocks engaged in pharmaceuticals, consumer products, medical devices, protective devices, animal welfare, and food businesses. The stock has surged by 5.92 percent after reporting a 29.79 percent YOY increase in net profit
Stock Price Movement
In Friday’s trading session, TTK Healthcare Limited’s share jumped to an intraday high of 5.92 percent from the previous close of Rs. 1,317. The stock is currently trading at Rs. 1,340, with a high of Rs. 1,395 and a low of Rs. 1,301. The market capitalization now stands at approximately Rs. 1,893.46 crore.
Q3 FY25 Result Walkthrough
Coming into the quarterly results of TTK Healthcare Limited, the company’s consolidated revenue from operations increased by 11.36 percent YOY, from Rs. 183.85 crore in Q3 FY24 to Rs. 204.74 crore in Q3 FY25, and grew by 3.15 percent QoQ from Rs. 198.49 crore in Q2 FY25.
The company has earned revenue from animal welfare by 16.03 percent, consumer products by 29 percent, medical devices by 10.48 percent, protective devices by 29 percent, foods by 15.47 percent, and other operating income by 0.03 percent in Q3 FY25.
In Q3 FY25, TTK Healthcare Limited’s consolidated net profit increased by 29.79 percent YOY, reaching Rs. 16.73 crore compared to Rs. 12.89 crore during the same period last year. As compared to Q2 FY25, the net profit has decreased by 2.81 percent, from Rs. 17.20 crore.
The basic earnings per share increased by 29.68 percent and stood at Rs 11.84 as against Rs 9.13 recorded in the same quarter in the previous year 2024.
Products Offering
The company provides a broad range of products across several categories, including pharmaceuticals, medical devices, consumer health products, and foods. This wide product portfolio allows the company to address different consumer needs, ensuring a strong presence in the healthcare and wellness sectors.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
